Bicycle Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Bicycle Therapeutics

04/05/2023 14:34

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of $1.30​​ per share for the quarter ended in March. The
mean expectation of fourteen analysts for the quarter was for a
loss of $1.07 per share.
    * Revenue rose 26.8% to $4.90 million from a year ago;
analysts
expected $3.88 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of $1.30​.
    * The mean earnings estimate of analysts had fallen by
about 3.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Bicycle Therapeutics PLC shares had risen by 2.6% this
quarter and lost 26.3% so far this year.
    * The company reported a quarterly loss of $39.06 million.
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $53.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.07          -1.30          Missed
 Dec. 31 2022      -1.06          -1.01          Beat
 Sep. 30 2022      -0.89          -0.96          Missed
 Jun. 30 2022      -0.85          -0.90          Missed